The case involves "skinny labels," which allow generic drugmakers to avoid patent lawsuits if a generic drug's label omits potentially infringing uses of a brand-name drug, per a Reuters report.
Pharmacists are well-positioned to deliver what’s needed to meet the clinical and economic burdens of community healthcare, particularly when it comes to diabetes care.